Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: A prospective randomized placebo-controlled double-blind study

Cindoruk M., Erkan G., Karakan T., Dursun A., Unal S.

HELICOBACTER, cilt.12, sa.4, ss.309-316, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 4
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1111/j.1523-5378.2007.00516.x
  • Dergi Adı: HELICOBACTER
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.309-316
  • Anahtar Kelimeler: H. pylori, S. boulardii, eradication, triple therapy, ANTIBIOTIC-ASSOCIATED DIARRHEA, GNOTOBIOTIC MURINE MODEL, ERADICATION THERAPY, CONTROLLED TRIAL, IN-VITRO, INFECTION, PREVENTION, PROBIOTICS, GASTRITIS, CHILDREN
  • Gazi Üniversitesi Adresli: Evet

Özet

Background: Recent studies indicate a potential role of Saccharomyces boulardii in the prevention of Helicobacter pylori treatment-related side-effects and also in improvement of eradication rate. Our aim is to investigate the efficacy and safety of S. boulardii in the prevention of side-effects related to H. pylori eradication. The secondary aim of the study was to define the effect of S. boulardii oil the eradication success of anti-H. pylori therapy.